Journal Information
Vol. 43. Issue 2.
Pages 126-128 (February 2007)
Share
Share
Download PDF
More article options
Vol. 43. Issue 2.
Pages 126-128 (February 2007)
Case Report
Full text access
Lung Transplantation: Bronchogenic Carcinoma in the Native Lung
Visits
3805
Juan Carlos Peñalver Cuesta
Corresponding author
jpenalve@ono.com

Correspondence: Dr. J.C. Peñalver Cuesta. Servicio de Cirugía Toracica. Hospital Universitario La Fe. Avda. Campanar, 21. 46009 Valencia. España
, Carlos Jordá Aragón, Juan Escrivá Peiró, José Cerón Navarro, Víctor Calvo Medina, José Padilla Alarcón
Servicio de Cirugía Torácica, Hospital Universitario La Fe, Valencia, Spain
This item has received
Article information

In lung transplantation, the presence of bronchogenic carcinoma in the native organ is uncommon, but doubtless affects patient survival, independently of the transplantation process itself.

We describe 2 cases in which a primary tumor was found in the explanted lung—1 case of adenocarcinoma in a patient with pulmonary emphysema and 1 case of bronchioloalveolar carcinoma in a patient with idiopathic pulmonary fibrosis. Both patients died due to the recurrence of the neoplastic disease. Distant metastasis was the initial manifestation of the recurrence.

Key words:
Lung transplantation
Bronchogenic carcinoma
Survival

En el trasplante pulmonar, la presencia de un carcinoma broncogénico en el órgano nativo es una situación muy poco frecuente, pero que, sin duda, condiciona la supervivencia de los pacientes, independientemente del propio proceso del trasplante en sí.

Se describen 2 casos donde se hallaron sendos tumores primarios pulmonares en el órgano extraído, un adenocarcinoma en el contexto de un enfisema pulmonar, y un carcinoma bronquioloalveolar en un paciente con fibrosis pulmonar idiopática. Ambos pacientes fallecieron por la recidiva de la enfermedad neoplásica, cuya manifestación inicial fue la presencia de enfermedad metastásica a distancia.

Palabras clave:
Trasplante pulmonar
Carcinoma broncogénico
Supervivencia
Full text is only aviable in PDF
REFERENCES
[1]
A Varela, A Alvarez Kindelan, A Roman, P Ussetti, F Zurbano.
Grupo de trabajo de la SEPAR. Normativa SEPAR. Trasplante pulmonar.
Arch Bronconeumol, 37 (2001), pp. 307-315
[2]
A Pacheco Gal van.
Expectativas en el paciente respiratorio terminal.
Arch Bronconeumol, 40 (2004), pp. 51-53
[3]
JM Borro.
Actualization del trasplante pulmonar en Espana.
Arch Bronconeumol, 41 (2005), pp. 457-467
[4]
A Salvatierra Velazquez.
Trasplante pulmonar en Espana.
Arch Bronconeumol, 40 (2004), pp. 41-48
[5]
SEPAR Grupo de Trabajo de la.
Normativa actualizada (1998) sobre diagnostico y estadificacion del carcinoma broncogenico.
Arch Bronconeumol, 34 (1998), pp. 437-452
[6]
I Penn.
Incidence and treatment of neoplasia after transplantation.
J Heart Lung Transplant, 12 (1993), pp. S328-SS36
[7]
YH Choi, AN Ieung, S Miro, C Pokier, S Hunt, J Theodore.
Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings.
J Thorac Imaging, 15 (2000), pp. 36-40
[8]
AC Anyanwu, ER Townsend, NR Banner, M Burke, A Khaghani, MH Yacoub.
Primary lung carcinoma after heart or lung transplantation: management and outcome.
J Thorac Cardiovasc Surg, 124 (2002), pp. 1190-1197
[9]
MS Shin, KJ Ho.
Recurrent bronchioloalveolar carcinoma after lung transplantation: radiographic and histologic features of the primary and recurrent tumors.
J Thorac Imaging, 19 (2004), pp. 79-81
[10]
S Stewart, K McNeil, SA Nashef, EC Wells, TW Higenbottam, J Wallwork.
Audit of referral and explant diagnoses in lung transplantation: a pathologic study of lungs removed for parenchymal disease.
J Heart Lung Transplant, 14 (1995), pp. 1173-1186
[11]
CA Svendsen, RB Bengtson, SJ Park, SJ Shumway.
Stage I adenocarcinoma presenting in the pneumonectomy specimen at the time of single lung transplantation.
Transplantation, 66 (1998), pp. 1108-1109
[12]
NA Abrahams, M Meziane, P Ramalingam, A Mehta, M deCamp, CF Farver.
Incidence of primary neoplasms in explanted lungs: long-term follow-up from 214 lung transplant patients.
Transplant Proc, 36 (2004), pp. 2808-2811
[13]
AR Glanville, M Estenne.
Indications, patient selection and timing of referral for lung transplantation.
Eur Respir J, 22 (2003), pp. 845-852
[14]
JR Maurer, AE Frost, M Estenne, T Higenbottam, AR Glanville.
International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.
J Heart Lung Transplant, 17 (1998), pp. 703-709
[15]
EA Kazerooni, LC Chow, RI Whyte, FJ Martinez, JP Iynch.
Preoperative examination of lung transplant candidates: value of chest CT compared with chest radiography.
AJR Am J Roentgenol, 165 (1995), pp. 1343-1348
[16]
D Hadjiliadis, VF Tapson, RD Davis, SM Palmer.
Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation.
J Heart Lung Transplant, 20 (2001), pp. 1305-1309
[17]
MC Resino, A Maldonado, L Garcia.
Utilidad de la tomografia de emision de positrones en el carcinoma de pulmon no microcitico.
Arch Bronconeumol, 40 (2004), pp. 103-105
[18]
FC Detterbeck, S Falen, MP Rivera, JS Halle, MA Socinski.
Seeking a home for a PET, part 1: defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses.
Chest, 125 (2004), pp. 2294-2299
[19]
RM Pieterman, JW Van Putten, JJ Meuzelaar, EL Mooyaart, W Vaalburg, GH Koeter, et al.
Preoperative staging of non-small-cell lung cancer with positron-emission tomography.
N Engl J Med, 343 (2000), pp. 254-261
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?